For details regarding exhibiting at ACI 2020, please contact Millbrook Medical Conferences on 01455 552559 or email ACI@millbrookconferences.co.uk
Exhibition Floor Plan
To download a copy of the exhibition floor plan, please use the link below.Download
File size: 2.37 Mb
PIONEERING VASCULAR SOLUTIONS
From essential vascular devices to next-generation technologies, our products are helping lay the foundation for better health outcomes every day. Minimally invasive treatments help speed recovery and let people get back to their daily activities faster with fewer complications, allowing healthier lives for millions of people worldwide.
We’re dedicated to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education. We have an industry-leading pipeline and comprehensive portfolio of products for cardiac and vascular care. And we’re committed to developing innovative technologies that have the potential to change the way physicians treat vascular disease.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Boston Scientific’s Interventional Cardiology division provides technologies for diagnosing and treating coronary artery disease, structural heart diseases and other cardiovascular disorders.
As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations, and the burden of chronic disease — faced by families and healthcare systems today. But, we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.
Biosensors International, improve patient’s lives through pioneering medical technology –
Featuring our proprietary anti-restenotic drug, Biolimus A9™, the polymer & carrier free, BioFreedom™ is the only commercially available stent approved for ultra-short 1 month DAPT in HBR patients and is the proven solution, enabling tailored DAPT to meet individual patients’ needs.
Biomatrix NeoFlex™ DES, Biomatrix Alpha™ DES, BioStreamTM DEB the RISE NC Balloon and the AllegraTM self-expanding, trans-femoral TAVI system complete our portfolio.
Cordis is a leader in the development and manufacture of interventional vascular technology with a more than 50-year history of delivering pioneering products to treat millions of patients worldwide. Cordis is committed to delivering the right combination of products, services and evidence to our customers and the patients they serve.
We look forward to meeting you at ACI to discuss and share the latest updates on Cordis Cardiovascular portfolio including the EluNIR™ Drug Eluting Stent, the new RAIN Sheath™, RAILWAY™ Sheathless Access system and Kaneka PTCA Balloons.
Philips Image Guided Therapy
As the leader in image guided therapy, we are committed to working with healthcare providers to help improve treatment for every patient. Our vision is to provide integrated solutions that advance minimally invasive procedures by helping healthcare providers to decide, guide, treat and confirm the right therapy for the right patient at the point of care. Working together to realize this vision, we can save and improve lives and reduce the total cost of care.
SMT is a leading manufacturer of minimally invasive Coronary intervention devices. The SMT journey started with a pledge, “Pledged to Save Millions” and has made a difference to Patients and Clinicians in over 75 countries. We continue to Inspire and be Inspired for Innovations in medical science that can improve healthcare and be affordable.
Minimising vessel trauma is Terumo’s core objective. Our leading edge TRI access and delivery systems allow cardiologists to perform procedures in a safer, faster and more comfortable way.
Terumo’s comprehensive portfolio includes the Ultimaster ™ Tansei Drug-Eluting Stent a range of balloon catheters, Ryujin ™, Accuforce ™ and our new Semi compliant balloon Ryurei ™ An extensive range of diagnostic catheters, unique microcatheters Finecross ™ & Dual Lumen microcatheter Fineduo ™, Runthrough ™ guidewires and a thrombo-aspiration device Eliminate ™. Not forgetting Terumo’s extensive introducer sheath range including Glidesheath Slender ™
From simple to challenging cases, Terumo’s products deliver outstanding performance.
Vascular Perspectives Ltd specialise in promoting unique and innovative products for use in interventional cardiology. Our representatives work throughout the United Kingdom providing high-level sales and educational support for clinical teams. We believe education is a critical component that allows clinicians to make the correct equipment choice and maximise procedural success. Working in partnership with key opinion leaders to communicate new ideas and techniques, we design informative educational programmes to support both products and procedures.
Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. For more information, visit www.edwards.com and follow us on Twitter @EdwardsLifesci.
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
HeartFlow is a digital health company uniquely positioned at the intersection of advanced artificial intelligence and healthcare to transform how heart disease is diagnosed and treated. Our non-invasive HeartFlow FFRct Analysis leverages deep learning to create a personalized 3D model of the heart. By using this model, clinicians can better evaluate the impact a blockage has on blood flow and determine the best treatment for patients. The HeartFlow Analysis is commercially available in the United States, Canada, Europe and Japan.
Merit Medical Systems, Inc. is a worldwide company engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic and therapeutic procedures. Our innovative products are designed to support procedures for the treatment of coronary and peripheral vascular disease from start to finish. We offer an integrated suite of interventional products to help optimize the efficiency of procedures.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anaesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.